ABSTRACT
Background Essential Hypertension (EH) is a global health issue. Despite extensive research, much of EH heritability remains unexplained. We investigated the genetic basis of EH in African-derived individuals from partially isolated quilombo populations in Vale do Ribeira (SP-Brazil).
Methods Samples from 431 individuals (167 affected, 261 unaffected, 3 unknown) were genotyped using a 650k SNP array. Estimated global ancestry proportions were 47% African, 36% European, and 16% Native American. We constructed six pedigrees using additional data from 673 individuals and created three non-overlapping SNP subpanels. We phased haplotypes and performed local ancestry analysis to account for admixture. Genome-wide linkage analysis (GWLA) and fine-mapping via family-based association studies (FBAS) were conducted, prioritizing EH-associated genes through systematic approach involving databases like PubMed, ClinVar, and GWAS Catalog.
Results Linkage analysis identified 22 regions of interest (ROIs) with LOD scores ranging 1.45-3.03, encompassing 2,363 genes. Fine-mapping (FBAS) identified 60 EH-related candidate genes and 117 suggestive/significant variants. Among these, 14 genes, including PHGDH, S100A10, MFN2, and RYR2, were strongly related to hypertension harboring 29 suggestive/significant SNPs.
Conclusions Through a complementary approach — combining admixture-adjusted GWLA based on Markov chain Monte Carlo methods, FBAS on known and imputed data, and gene prioritizing — new loci, variants, and candidate genes were identified. These findings provide targets for future research, replication in other populations, facilitate personalized treatments, and improve public health towards African-derived underrepresented populations. Limitations include restricted SNP coverage, self-reported pedigree data, and lack of available EH genomic studies on admixed populations for independent validation, despite the performed genetic correlation analyses using summary statistics.
What Is New?This study applies a multi-level computational approach integrating admixture-adjusted genome-wide linkage analysis (GWLA), family-based association studies (FBAS), and fine-mapping strategies to investigate the genetic basis of essential hypertension (EH) in Brazilian Quilombo populations, a historically underrepresented group in genomic research.
What Is Relevant?By focusing on admixed populations with high African ancestry, our findings address gaps in hypertension genetics by identifying 22 regions of interest (ROIs), 60 candidate genes, and 117 suggestive/significant variants, highlighting population-specific genetic factors that may contribute to EH risk. The study also emphasizes the need for ancestry-aware genomic analyses to improve the precision of genetic risk assessment in underrepresented populations.
What Question Should Be Addressed Next?Future studies should focus on replicating these findings in independent admixed cohorts, conducting functional validation of prioritized genes, and integrating polygenic risk scores (PRS) adjusted for ancestry to enhance clinical applications for hypertension prevention and treatment in diverse populations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We acknowledge funding from CEPID-FAPESP (Research Center on the Human Genome and Stem Cells, grants 1998/14254-2 and 2013/08028-1, and FAPESP/INCT-CNPq 2014/50931-3). This research also received support from grant FAPESP 2012/18010-0, titled Balancing selection in the human genome: detection, causes, and consequences. Additionally, we are grateful to CAPES for the sandwich Ph.D. fellowship #88887.371219/2019-00 and CNPq for the Ph.D. fellowship #142193/2017-8. We also acknowledge funding from the Marshall University Joan C. Edwards School of Medicine, WV-INBRE grant (NIH P20GM103434), Bench-to-Bedside Pilot grant (Nato) under the West Virginia Clinical and Translational Science Institute (WV-CTSI) grant (NIH 5U54GM104942), and Nato startup fund.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of University of Sao Paulo (Brazil)/Institute of Biomedical Sciences gave ethical approval for this work under the protocol number 111/2001. Ethics committee/IRB of University of Sao Paulo (Brazil)/Institute of Biosciences gave ethical approval for this work under the protocol number 012/2004 and 034/2005.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Formatting adjustments, improving the text flow.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
NON-STANDARD ABBREVIATIONS AND ACRONYMS
- ABDR
- Abobral (quilombo population)
- AGT
- angiotensinogen
- ALPK2
- alpha kinase 2
- AN
- André Lopes (quilombo population)
- ANG II
- angiotensin II
- ANP
- atrial natriuretic peptide
- ARMC
- armadillo repeat containing 5
- BMI
- body mass index
- BP
- arterial blood pressure
- CACNA1D
- calcium voltage-gated channel subunit alpha1 d
- CADD
- combined annotation dependent depletion
- CEU
- Northern Europeans from Utah
- CLM
- Colombian in Medellin, Colombia
- CVDs
- cardiovascular diseases
- CYP11B2
- cytochrome p450 family 11 subfamily b member 2
- DBP
- diastolic blood pressure
- EDARADD
- edar associated via death domain
- EH
- essential hypertension
- eNOS
- endothelial nitric oxide synthase
- GA
- Galvão (quilombo population)
- GLMM
- generalized linear mixed model
- GRK4
- g protein-coupled receptor kinase 4
- GRM
- genetic relationship matrix
- HGDP
- human genome diversity project
- IV
- Ivaporunduva (quilombo population)
- IVs
- inheritance vectors
- KCNK3
- potassium two pore domain channel subfamily k member 3
- KCNT1
- potassium sodium-activated channel subfamily t member 1
- KKS
- kallikrein-kinin system
- LD
- linkage disequilibrium
- LINC01256
- long intergenic non-protein coding rna 1256
- LOD
- logarithm of the odds
- LPP
- lim domain containing preferred translocation partner in lipoma
- MCMC
- markov chain monte carlo
- MFN2
- mitofusin 2
- MLX
- Mexican Ancestry in Los Angeles, California
- MOBP
- myelin associated oligodendrocyte basic protein
- MTR
- 5-methyltetrahydrofolate-homocysteine methyltransferase
- NH
- Nhunguara (quilombo population)
- NO
- nitric oxide
- NOS3
- nitric oxide synthase 3
- NPR3
- natriuretic peptide receptor 3
- P2RX1
- purinergic receptor p2x 1
- P2RY1
- purinergic receptor p2y1
- PC
- Pedro Cubas (quilombo population)
- PCA
- principal components analysis
- PCs
- principal components
- PEL
- Peruvian in Lima, Peru
- PHGDH
- phosphoglycerate dehydrogenase
- PHOX2
- paired like homeobox 2
- PUR
- Puerto Rican in Puerto Rico
- RAAS
- renin-angiotensin-aldosterone system
- ROIs
- regions of interest
- RPA1
- replication protein a1
- RYR2
- ryanodine receptor 2
- S100A10
- s100 calcium binding protein a10
- SBP
- systolic blood pressure
- SCG2
- secretogranin ii
- SCNN1B
- sodium channel epithelial 1 subunit beta
- SCNN1G
- sodium channel epithelial 1 subunit gamma
- SERTAD2
- serta domain containing 2
- SNS
- sympathetic nervous system
- SP
- São Pedro (quilombo population)
- TENM4
- teneurin transmembrane protein 4
- TF
- transcription factor
- TU
- Sapatu (quilombo population)
- YRI
- Yoruba in Ibadan, Nigeria
- ZZEF1
- zinc finger zz-type and ef-hand domain containing 1